Global Acquired Hemophilia Treatment Market Growth (Status and Outlook) 2025-2031

September 2025 | 98 pages | ID: G406722302E3EN
LP Information

Abstracts

According to this study, the global Acquired Hemophilia Treatment market size will reach US$ million by 2031.

Acquired hemophilia is a rare autoimmune disorder characterized by bleeding that occurs in patients with a personal and family history negative for hemorrhages.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Acquired Hemophilia Treatment Industry Forecast” looks at past sales and reviews total world Acquired Hemophilia Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Acquired Hemophilia Treatment sales for 2025 through 2031. With Acquired Hemophilia Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acquired Hemophilia Treatment industry.

This Insight Report provides a comprehensive analysis of the global Acquired Hemophilia Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Acquired Hemophilia Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Acquired Hemophilia Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acquired Hemophilia Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acquired Hemophilia Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Acquired Hemophilia Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Traditional Therapy
• Advanced Therapy

Segmentation by Application:

• Hospitals
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Baxalta, Inc.
• Baxter Healthcare Corporation
• Bristol-Myers Squibb
• Genentech, Inc.
• Novo Nordisk A/S
• Ferring B.V.
• Sanofi SA

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Acquired Hemophilia Treatment Market Size (2020-2031)
  2.1.2 Acquired Hemophilia Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Acquired Hemophilia Treatment by Country/Region (2020, 2024 & 2031)
2.2 Acquired Hemophilia Treatment Segment by Type
  2.2.1 Traditional Therapy
  2.2.2 Advanced Therapy
2.3 Acquired Hemophilia Treatment Market Size by Type
  2.3.1 Acquired Hemophilia Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Acquired Hemophilia Treatment Market Size Market Share by Type (2020-2025)
2.4 Acquired Hemophilia Treatment Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinic
  2.4.3 Others
2.5 Acquired Hemophilia Treatment Market Size by Application
  2.5.1 Acquired Hemophilia Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Acquired Hemophilia Treatment Market Size Market Share by Application (2020-2025)

3 ACQUIRED HEMOPHILIA TREATMENT MARKET SIZE BY PLAYER

3.1 Acquired Hemophilia Treatment Market Size Market Share by Player
  3.1.1 Global Acquired Hemophilia Treatment Revenue by Player (2020-2025)
  3.1.2 Global Acquired Hemophilia Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Acquired Hemophilia Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ACQUIRED HEMOPHILIA TREATMENT BY REGION

4.1 Acquired Hemophilia Treatment Market Size by Region (2020-2025)
4.2 Global Acquired Hemophilia Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Acquired Hemophilia Treatment Market Size Growth (2020-2025)
4.4 APAC Acquired Hemophilia Treatment Market Size Growth (2020-2025)
4.5 Europe Acquired Hemophilia Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Acquired Hemophilia Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Acquired Hemophilia Treatment Market Size by Country (2020-2025)
5.2 Americas Acquired Hemophilia Treatment Market Size by Type (2020-2025)
5.3 Americas Acquired Hemophilia Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Acquired Hemophilia Treatment Market Size by Region (2020-2025)
6.2 APAC Acquired Hemophilia Treatment Market Size by Type (2020-2025)
6.3 APAC Acquired Hemophilia Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Acquired Hemophilia Treatment Market Size by Country (2020-2025)
7.2 Europe Acquired Hemophilia Treatment Market Size by Type (2020-2025)
7.3 Europe Acquired Hemophilia Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Acquired Hemophilia Treatment by Region (2020-2025)
8.2 Middle East & Africa Acquired Hemophilia Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Acquired Hemophilia Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ACQUIRED HEMOPHILIA TREATMENT MARKET FORECAST

10.1 Global Acquired Hemophilia Treatment Forecast by Region (2026-2031)
  10.1.1 Global Acquired Hemophilia Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Acquired Hemophilia Treatment Forecast
  10.1.3 APAC Acquired Hemophilia Treatment Forecast
  10.1.4 Europe Acquired Hemophilia Treatment Forecast
  10.1.5 Middle East & Africa Acquired Hemophilia Treatment Forecast
10.2 Americas Acquired Hemophilia Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Acquired Hemophilia Treatment Forecast
  10.2.2 Canada Market Acquired Hemophilia Treatment Forecast
  10.2.3 Mexico Market Acquired Hemophilia Treatment Forecast
  10.2.4 Brazil Market Acquired Hemophilia Treatment Forecast
10.3 APAC Acquired Hemophilia Treatment Forecast by Region (2026-2031)
  10.3.1 China Acquired Hemophilia Treatment Market Forecast
  10.3.2 Japan Market Acquired Hemophilia Treatment Forecast
  10.3.3 Korea Market Acquired Hemophilia Treatment Forecast
  10.3.4 Southeast Asia Market Acquired Hemophilia Treatment Forecast
  10.3.5 India Market Acquired Hemophilia Treatment Forecast
  10.3.6 Australia Market Acquired Hemophilia Treatment Forecast
10.4 Europe Acquired Hemophilia Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Acquired Hemophilia Treatment Forecast
  10.4.2 France Market Acquired Hemophilia Treatment Forecast
  10.4.3 UK Market Acquired Hemophilia Treatment Forecast
  10.4.4 Italy Market Acquired Hemophilia Treatment Forecast
  10.4.5 Russia Market Acquired Hemophilia Treatment Forecast
10.5 Middle East & Africa Acquired Hemophilia Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Acquired Hemophilia Treatment Forecast
  10.5.2 South Africa Market Acquired Hemophilia Treatment Forecast
  10.5.3 Israel Market Acquired Hemophilia Treatment Forecast
  10.5.4 Turkey Market Acquired Hemophilia Treatment Forecast
10.6 Global Acquired Hemophilia Treatment Forecast by Type (2026-2031)
10.7 Global Acquired Hemophilia Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Acquired Hemophilia Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Baxalta, Inc.
  11.1.1 Baxalta, Inc. Company Information
  11.1.2 Baxalta, Inc. Acquired Hemophilia Treatment Product Offered
  11.1.3 Baxalta, Inc. Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Baxalta, Inc. Main Business Overview
  11.1.5 Baxalta, Inc. Latest Developments
11.2 Baxter Healthcare Corporation
  11.2.1 Baxter Healthcare Corporation Company Information
  11.2.2 Baxter Healthcare Corporation Acquired Hemophilia Treatment Product Offered
  11.2.3 Baxter Healthcare Corporation Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Baxter Healthcare Corporation Main Business Overview
  11.2.5 Baxter Healthcare Corporation Latest Developments
11.3 Bristol-Myers Squibb
  11.3.1 Bristol-Myers Squibb Company Information
  11.3.2 Bristol-Myers Squibb Acquired Hemophilia Treatment Product Offered
  11.3.3 Bristol-Myers Squibb Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Bristol-Myers Squibb Main Business Overview
  11.3.5 Bristol-Myers Squibb Latest Developments
11.4 Genentech, Inc.
  11.4.1 Genentech, Inc. Company Information
  11.4.2 Genentech, Inc. Acquired Hemophilia Treatment Product Offered
  11.4.3 Genentech, Inc. Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Genentech, Inc. Main Business Overview
  11.4.5 Genentech, Inc. Latest Developments
11.5 Novo Nordisk A/S
  11.5.1 Novo Nordisk A/S Company Information
  11.5.2 Novo Nordisk A/S Acquired Hemophilia Treatment Product Offered
  11.5.3 Novo Nordisk A/S Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Novo Nordisk A/S Main Business Overview
  11.5.5 Novo Nordisk A/S Latest Developments
11.6 Ferring B.V.
  11.6.1 Ferring B.V. Company Information
  11.6.2 Ferring B.V. Acquired Hemophilia Treatment Product Offered
  11.6.3 Ferring B.V. Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Ferring B.V. Main Business Overview
  11.6.5 Ferring B.V. Latest Developments
11.7 Sanofi SA
  11.7.1 Sanofi SA Company Information
  11.7.2 Sanofi SA Acquired Hemophilia Treatment Product Offered
  11.7.3 Sanofi SA Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Sanofi SA Main Business Overview
  11.7.5 Sanofi SA Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Acquired Hemophilia Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Acquired Hemophilia Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Traditional Therapy
Table 4. Major Players of Advanced Therapy
Table 5. Acquired Hemophilia Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Acquired Hemophilia Treatment Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Acquired Hemophilia Treatment Market Size Market Share by Type (2020-2025)
Table 8. Acquired Hemophilia Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Acquired Hemophilia Treatment Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Acquired Hemophilia Treatment Market Size Market Share by Application (2020-2025)
Table 11. Global Acquired Hemophilia Treatment Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Acquired Hemophilia Treatment Revenue Market Share by Player (2020-2025)
Table 13. Acquired Hemophilia Treatment Key Players Head office and Products Offered
Table 14. Acquired Hemophilia Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Acquired Hemophilia Treatment Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Acquired Hemophilia Treatment Market Size Market Share by Region (2020-2025)
Table 19. Global Acquired Hemophilia Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Acquired Hemophilia Treatment Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Acquired Hemophilia Treatment Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Acquired Hemophilia Treatment Market Size Market Share by Country (2020-2025)
Table 23. Americas Acquired Hemophilia Treatment Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Acquired Hemophilia Treatment Market Size Market Share by Type (2020-2025)
Table 25. Americas Acquired Hemophilia Treatment Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Acquired Hemophilia Treatment Market Size Market Share by Application (2020-2025)
Table 27. APAC Acquired Hemophilia Treatment Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Acquired Hemophilia Treatment Market Size Market Share by Region (2020-2025)
Table 29. APAC Acquired Hemophilia Treatment Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Acquired Hemophilia Treatment Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Acquired Hemophilia Treatment Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Acquired Hemophilia Treatment Market Size Market Share by Country (2020-2025)
Table 33. Europe Acquired Hemophilia Treatment Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Acquired Hemophilia Treatment Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Acquired Hemophilia Treatment Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Acquired Hemophilia Treatment Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Acquired Hemophilia Treatment Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Acquired Hemophilia Treatment
Table 39. Key Market Challenges & Risks of Acquired Hemophilia Treatment
Table 40. Key Industry Trends of Acquired Hemophilia Treatment
Table 41. Global Acquired Hemophilia Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Acquired Hemophilia Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Acquired Hemophilia Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Acquired Hemophilia Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Baxalta, Inc. Details, Company Type, Acquired Hemophilia Treatment Area Served and Its Competitors
Table 46. Baxalta, Inc. Acquired Hemophilia Treatment Product Offered
Table 47. Baxalta, Inc. Acquired Hemophilia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Baxalta, Inc. Main Business
Table 49. Baxalta, Inc. Latest Developments
Table 50. Baxter Healthcare Corporation Details, Company Type, Acquired Hemophilia Treatment Area Served and Its Competitors
Table 51. Baxter Healthcare Corporation Acquired Hemophilia Treatment Product Offered
Table 52. Baxter Healthcare Corporation Acquired Hemophilia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Baxter Healthcare Corporation Main Business
Table 54. Baxter Healthcare Corporation Latest Developments
Table 55. Bristol-Myers Squibb Details, Company Type, Acquired Hemophilia Treatment Area Served and Its Competitors
Table 56. Bristol-Myers Squibb Acquired Hemophilia Treatment Product Offered
Table 57. Bristol-Myers Squibb Acquired Hemophilia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Bristol-Myers Squibb Main Business
Table 59. Bristol-Myers Squibb Latest Developments
Table 60. Genentech, Inc. Details, Company Type, Acquired Hemophilia Treatment Area Served and Its Competitors
Table 61. Genentech, Inc. Acquired Hemophilia Treatment Product Offered
Table 62. Genentech, Inc. Acquired Hemophilia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Genentech, Inc. Main Business
Table 64. Genentech, Inc. Latest Developments
Table 65. Novo Nordisk A/S Details, Company Type, Acquired Hemophilia Treatment Area Served and Its Competitors
Table 66. Novo Nordisk A/S Acquired Hemophilia Treatment Product Offered
Table 67. Novo Nordisk A/S Acquired Hemophilia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Novo Nordisk A/S Main Business
Table 69. Novo Nordisk A/S Latest Developments
Table 70. Ferring B.V. Details, Company Type, Acquired Hemophilia Treatment Area Served and Its Competitors
Table 71. Ferring B.V. Acquired Hemophilia Treatment Product Offered
Table 72. Ferring B.V. Acquired Hemophilia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Ferring B.V. Main Business
Table 74. Ferring B.V. Latest Developments
Table 75. Sanofi SA Details, Company Type, Acquired Hemophilia Treatment Area Served and Its Competitors
Table 76. Sanofi SA Acquired Hemophilia Treatment Product Offered
Table 77. Sanofi SA Acquired Hemophilia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Sanofi SA Main Business
Table 79. Sanofi SA Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Acquired Hemophilia Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Acquired Hemophilia Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Acquired Hemophilia Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Acquired Hemophilia Treatment Sales Market Share by Country/Region (2024)
Figure 8. Acquired Hemophilia Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Acquired Hemophilia Treatment Market Size Market Share by Type in 2024
Figure 10. Acquired Hemophilia Treatment in Hospitals
Figure 11. Global Acquired Hemophilia Treatment Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Acquired Hemophilia Treatment in Clinic
Figure 13. Global Acquired Hemophilia Treatment Market: Clinic (2020-2025) & ($ millions)
Figure 14. Acquired Hemophilia Treatment in Others
Figure 15. Global Acquired Hemophilia Treatment Market: Others (2020-2025) & ($ millions)
Figure 16. Global Acquired Hemophilia Treatment Market Size Market Share by Application in 2024
Figure 17. Global Acquired Hemophilia Treatment Revenue Market Share by Player in 2024
Figure 18. Global Acquired Hemophilia Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Acquired Hemophilia Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Acquired Hemophilia Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Acquired Hemophilia Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Acquired Hemophilia Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Acquired Hemophilia Treatment Value Market Share by Country in 2024
Figure 24. United States Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Acquired Hemophilia Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Acquired Hemophilia Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Acquired Hemophilia Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Acquired Hemophilia Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Acquired Hemophilia Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Acquired Hemophilia Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Acquired Hemophilia Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Acquired Hemophilia Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Acquired Hemophilia Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Acquired Hemophilia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Acquired Hemophilia Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Acquired Hemophilia Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Acquired Hemophilia Treatment Market Size 2026-2031 ($ millions)